Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cagdas Kaya, Souska Zandi, Isabel B Pfister, Christin Gerhardt & Justus G Garweg. (2019) Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration. Clinical Ophthalmology 13, pages 2403-2409.
Read now
Read now
Shiqi Yang, Jingke Zhao & Xiaodong Sun. (2016) Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Design, Development and Therapy 10, pages 1857-1867.
Read now
Read now
Wenbo Li, Lijie Dong, Minwang Ma, Bojie Hu, Zhenyu Lu, Xun Liu, Juping Liu & Xiaorong Li. (2016) Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration. Drug Design, Development and Therapy 10, pages 3415-3423.
Read now
Read now
Articles from other publishers (10)
Jouri S. Alanazi, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Awwad A. Radwan, Ahmed Bari, Qamraa Hamad Alqahtani, Hosam Gharib Abdelhady & Ibrahim Alsarra. (2022) MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization. Pharmaceutics 14:2, pages 243.
Crossref
Crossref
V. G. Likhvantseva, V. N. Trubilin, S. G. Kapkova & A. S. Gevorgyan. (2021) To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review. Ophthalmology in Russia 18:3, pages 389-398.
Crossref
Crossref
O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya & E.V. Bobykin. (2021) Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response. Vestnik oftal'mologii 137:5, pages 152.
Crossref
Crossref
Tomohiro Nizawa, Masayasu Kitahashi, Takayuki Baba, Takehito Iwase, Mariko Kubota-Taniai, Yoko Hattori, Yuki Shiko, Yohei Kawasaki, Takayuki Iwase, Takatoshi Sato, Shoko Ogawa, Takeshi Sugawara & Shuichi Yamamoto. (2021) Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy. Ophthalmologica 244:4, pages 347-360.
Crossref
Crossref
Fangfang Qiu, Tuo Meng, Qian Chen, Kelu Zhou, Yan Shao, Greg Matlock, Xiang Ma, Wenjing Wu, Yanhong Du, Xiang Wang, Guotao Deng, Jian-xing Ma & Qingguo Xu. (2019) Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Molecular Pharmaceutics 16:5, pages 1958-1970.
Crossref
Crossref
Xinyuan Zhang & Timothy Y. Y. Lai. (2018) Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
M. V. Budzinskaya, A. A. Plyukhova & P. A. Sorokin. (2017) Anti-VEGF therapy resistance in neovascular age-related macular degeneration. Vestnik oftal'mologii 133:4, pages 103.
Crossref
Crossref
Lei Zheng, Chen Zhao, Yuxiang Du, Xianchai Lin, Yida Jiang, Chunsik Lee, Geng Tian, Jia Mi, Xianglin Li, Qishan Chen, Zhimin Ye, Lijuan Huang, Shasha Wang, Xiangrong Ren, Liying Xing, Wei Chen, Delong Huang, Zhiqin Gao, Shuping Zhang, Weisi Lu, Zhongshu Tang, Bin Wang, Rong Ju & Xuri Li. (2016) PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently. Oncotarget 7:47, pages 77902-77915.
Crossref
Crossref
Charles Wright & Jayakrishna Ambati. 2016. Advances in Geroscience. Advances in Geroscience
471
507
.
Joel Hanhart & Itay Chowers. (2015) Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema. Case Reports in Ophthalmology 6:1, pages 44-50.
Crossref
Crossref